Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 121

1.

Clinical protocols for ³¹P MRS of the brain and their use in evaluating optic pathway gliomas in children.

Novak J, Wilson M, Macpherson L, Arvanitis TN, Davies NP, Peet AC.

Eur J Radiol. 2014 Feb;83(2):e106-12. doi: 10.1016/j.ejrad.2013.11.009. Epub 2013 Nov 25.

2.

(1)H magnetic resonance spectroscopy in the diagnosis of paediatric low grade brain tumours.

Orphanidou-Vlachou E, Auer D, Brundler MA, Davies NP, Jaspan T, MacPherson L, Natarajan K, Sun Y, Arvanitis TN, Grundy RG, Peet AC.

Eur J Radiol. 2013 Jun;82(6):e295-301. doi: 10.1016/j.ejrad.2013.01.030. Epub 2013 Mar 13.

PMID:
23489978
3.

Cutoff value of choline concentration reliably reveals high-grade brain tumors among other contrast-enhancing brain lesions.

Porto L, Hattingen E, Stuecher A, Herminghaus S, Lanfermann H, Ulrich Pilatus UP.

J Neurol Surg A Cent Eur Neurosurg. 2012 May;73(3):147-52. doi: 10.1055/s-0032-1313723. Epub 2012 May 3.

PMID:
22190143
4.

Metabolic mapping of gliomas using hybrid MR-PET imaging: feasibility of the method and spatial distribution of metabolic changes.

Bisdas S, Ritz R, Bender B, Braun C, Pfannenberg C, Reimold M, Naegele T, Ernemann U.

Invest Radiol. 2013 May;48(5):295-301. doi: 10.1097/RLI.0b013e31827188d6.

PMID:
23296081
5.

Diagnostic and prognostic value of 18F-DOPA PET and 1H-MR spectroscopy in pediatric supratentorial infiltrative gliomas: a comparative study.

Morana G, Piccardo A, Puntoni M, Nozza P, Cama A, Raso A, Mascelli S, Massollo M, Milanaccio C, Garrè ML, Rossi A.

Neuro Oncol. 2015 Dec;17(12):1637-47. doi: 10.1093/neuonc/nov099. Epub 2015 Sep 23.

7.

A quantitative comparison of metabolite signals as detected by in vivo MRS with ex vivo 1H HR-MAS for childhood brain tumours.

Wilson M, Davies NP, Grundy RG, Peet AC.

NMR Biomed. 2009 Feb;22(2):213-9. doi: 10.1002/nbm.1306.

PMID:
19067434
8.

Recognition of anaplastic foci within low-grade gliomas using MR spectroscopy.

Bradac O, Vrana J, Jiru F, Kramar F, Netuka D, Hrabal P, Horinek D, de Lacy P, Benes V.

Br J Neurosurg. 2014 Oct;28(5):631-6. doi: 10.3109/02688697.2013.872229. Epub 2013 Dec 30.

PMID:
24377726
9.

Oral administration of choline does not affect metabolic characteristics of gliomas and normal-appearing white matter, as detected with single-voxel (1)H-MRS at 1.5 T.

Chernov MF, Muragaki Y, Maruyama T, Ono Y, Usukura M, Yoshida S, Nakamura R, Iseki H, Kubo O, Hori T, Takakura K.

Neuroradiology. 2009 Mar;51(3):137-43. doi: 10.1007/s00234-008-0471-x. Epub 2008 Oct 24.

PMID:
18949472
10.

[Magnetic resonance spectroscopy of brain tumors].

Ditter P, Hattingen E.

Radiologe. 2017 Jun;57(6):450-458. doi: 10.1007/s00117-017-0241-z. German.

PMID:
28331947
11.

Comparison between magnetic resonance spectroscopy and diffusion weighted imaging in the evaluation of gliomas response after treatment.

Lotumolo A, Caivano R, Rabasco P, Iannelli G, Villonio A, D' Antuono F, Gioioso M, Zandolino A, Macarini L, Guglielmi G, Cammarota A.

Eur J Radiol. 2015 Dec;84(12):2597-604. doi: 10.1016/j.ejrad.2015.09.005. Epub 2015 Sep 11.

PMID:
26391231
12.

Correlation between choline and MIB-1 index in human gliomas. A quantitative in proton MR spectroscopy study.

Matsumura A, Isobe T, Anno I, Takano S, Kawamura H.

J Clin Neurosci. 2005 May;12(4):416-20.

PMID:
15925772
13.

Diagnostic potential of short echo time MR spectroscopy of gliomas with single-voxel and point-resolved spatially localised proton spectroscopy of brain.

Kaminogo M, Ishimaru H, Morikawa M, Ochi M, Ushijima R, Tani M, Matsuo Y, Kawakubo J, Shibata S.

Neuroradiology. 2001 May;43(5):353-63.

PMID:
11396738
14.

Proton magnetic resonance spectroscopy in the distinction of high-grade cerebral gliomas from single metastatic brain tumors.

Server A, Josefsen R, Kulle B, Maehlen J, Schellhorn T, Gadmar Ø, Kumar T, Haakonsen M, Langberg CW, Nakstad PH.

Acta Radiol. 2010 Apr;51(3):316-25. doi: 10.3109/02841850903482901.

PMID:
20092374
15.

Malignancy assessment of brain tumours with magnetic resonance spectroscopy and dynamic susceptibility contrast MRI.

Fayed N, Dávila J, Medrano J, Olmos S.

Eur J Radiol. 2008 Sep;67(3):427-33. doi: 10.1016/j.ejrad.2008.02.039. Epub 2008 Apr 28.

PMID:
18442889
16.

Measurements of diagnostic examination performance using quantitative apparent diffusion coefficient and proton MR spectroscopic imaging in the preoperative evaluation of tumor grade in cerebral gliomas.

Server A, Kulle B, Gadmar ØB, Josefsen R, Kumar T, Nakstad PH.

Eur J Radiol. 2011 Nov;80(2):462-70. doi: 10.1016/j.ejrad.2010.07.017. Epub 2010 Aug 13.

PMID:
20708868
17.

Metabolic approach for tumor delineation in glioma surgery: 3D MR spectroscopy image-guided resection.

Zhang J, Zhuang DX, Yao CJ, Lin CP, Wang TL, Qin ZY, Wu JS.

J Neurosurg. 2016 Jun;124(6):1585-93. doi: 10.3171/2015.6.JNS142651. Epub 2015 Dec 4.

PMID:
26636387
18.

Biopsy targeting gliomas: do functional imaging techniques identify similar target areas?

Weber MA, Henze M, Tüttenberg J, Stieltjes B, Meissner M, Zimmer F, Burkholder I, Kroll A, Combs SE, Vogt-Schaden M, Giesel FL, Zoubaa S, Haberkorn U, Kauczor HU, Essig M.

Invest Radiol. 2010 Dec;45(12):755-68. doi: 10.1097/RLI.0b013e3181ec9db0.

PMID:
20829706
19.

Noninvasive evaluation of cerebral glioma grade by using multivoxel 3D proton MR spectroscopy.

Zeng Q, Liu H, Zhang K, Li C, Zhou G.

Magn Reson Imaging. 2011 Jan;29(1):25-31. doi: 10.1016/j.mri.2010.07.017. Epub 2010 Sep 15.

PMID:
20832225
20.

Molecular and metabolic pattern classification for detection of brain glioma progression.

Imani F, Boada FE, Lieberman FS, Davis DK, Mountz JM.

Eur J Radiol. 2014 Feb;83(2):e100-5. doi: 10.1016/j.ejrad.2013.06.033. Epub 2013 Nov 20.

Supplemental Content

Support Center